# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002019410-25-000012
Filing Date
2025-08-12
Accepted
2025-08-12 16:59:53
Documents
84
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cai-20250630.htm iXBRL | 10-Q | 2643023
2 | EX-10.3(A)(2) | exhibit103a2-cariswpt2ndam.htm | EX-10.3(A)(2) | 59509
3 | EX-31.1 302 CEO CERTIFICATION | ex311-302certificationceo.htm | EX-31.1 | 9338
4 | EX-31.2 302 CFO CERTIFICATION | ex312-302certificationcfo.htm | EX-31.2 | 9129
5 | EX-32.1 906 CEO CERTIFICATION | ex321-906certificationceo.htm | EX-32.1 | 4421
6 | EX-32.2 906 CFO CERTIFICATION | ex322-906certificationcfo.htm | EX-32.2 | 4454
| Complete submission text file | 0002019410-25-000012.txt |  | 11225200

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cai-20250630.xsd | EX-101.SCH | 66028
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cai-20250630_cal.xml | EX-101.CAL | 69776
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cai-20250630_def.xml | EX-101.DEF | 467753
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cai-20250630_lab.xml | EX-101.LAB | 836876
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cai-20250630_pre.xml | EX-101.PRE | 651217
87 | EXTRACTED XBRL INSTANCE DOCUMENT | cai-20250630_htm.xml | XML | 1447723

Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42706 | Film No.: 251207673
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)